Keywords: Lundbeck, Sycrest, Saphris, Janssen, Intelence, Bipolar 1 disorder, HIV, UK launch

Two UK product launches

Article | 16 January 2012

Print This

Danish drugmaker Lundbeck (LUND: DC) announced yesterday that Sycrest (asenapine) is being launched in the UK for the treatment of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in